Test description
Testing (next generation sequencing) for IDH1 and IDH2 variants in tumour tissue in patients with clinical or laboratory evidence of glial neoplasms.
Test information
Test name
IDH1/2
Clinical indication
Testing in patients with negative IDH1 immunohistochemistry (IHC) and clinical or laboratory evidence of glial neoplasm. Information from this testing may assist in diagnosis and prognostication.
Gene(s)
IDH1/2
Method
NGS Oncomine Precision Assay
Turn around time
1 week from receipt of sample
Medicare eligibility
73372 criteria apply
Price
If not MBS eligible. Please contact 1800 822 999 for pricing details
Test request form
Standard pathology request form
Sample type
FFPE Tumour Tissue
Collection type
N/A
Special instructions
6 x 5 micron slides plus 1 x H&E stained slide required
FAQ
No items found.
Resources
No items found.